Viewing Study NCT03619993

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:16 AM
Ignite Modification Date: 2026-02-28 @ 11:21 AM
Study NCT ID: NCT03619993
Status: COMPLETED
Last Update Posted: 2019-12-17
First Post: 2018-06-19
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Patient Preference for Pegfilgrastim (Neulasta®) Application Forms
Sponsor: iOMEDICO AG
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non Hodgkin Lymphoma View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None R-CHOP View
None G-CSF View
None Early breast cancer View
None Anthracycline/cyclophosphamide View
None 1st line View
None immunochemotherapy View
None taxane View